Innovative Diagnosis Tool EarliTec Diagnostics offers the EarliPoint System, a cutting-edge eye-tracking device designed to facilitate early autism diagnosis in children aged 16 to 30 months, presenting an opportunity to partner with healthcare providers seeking reliable early screening solutions.

Recent Funding & Growth With a successful Series B funding of 21.5 million dollars led by prominent venture investors, EarliTec is positioned to expand its market reach, accelerate product commercialization, and enhance its diagnostic technologies, creating multiple sales avenues.

Strategic Leadership Appointment The recent appointment of Jamie Pagliaro as CEO signals a potential shift towards aggressive growth and strategic partnerships, making this a key time to engage with company leadership regarding sales collaborations.

Market Expansion Potential Having launched the EarliPoint system for clinical use and collaborating with healthcare providers, EarliTec is expanding into early intervention markets, indicating opportunities to connect with clinics and pediatric specialists increasingly adopting early ASD screening tools.

Industry Positioning As a smaller player compared to larger autism-related nonprofit organizations, EarliTec presents a niche opportunity for compatible medical equipment providers and service partners to establish tailored solutions and integrate with their diagnostic workflows.